Rhumbline Advisers Purchases 9,935 Shares of Can-Fite BioPharma Ltd. (NYSE:CANF)
Rhumbline Advisers increased its position in Can-Fite BioPharma Ltd. (NYSE:CANF – Free Report) by 58.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,880 shares of the company’s stock after acquiring an additional 9,935 shares during the period. Rhumbline Advisers’ holdings in Can-Fite […]
Rhumbline Advisers increased its position in Can-Fite BioPharma Ltd. (NYSE:CANF – Free Report) by 58.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,880 shares of the company’s stock after acquiring an additional 9,935 shares during the period. Rhumbline Advisers’ holdings in Can-Fite […]
